Hide Board Information

Show Board Information

Raphael Pharmaceutical Inc RAPH

Board Mod: louied91

Asst Mods:

Last Post: 01/07/2025 9:20:00 AM

Board Marks: 0

Posts Today: 0

Board Views Today: 4

Raphael Pharmaceutical Inc. (“Raphael”) (OTCQB: RAPH) is a clinical-stage biotechnology company focused on advancing a novel cannabinoid-based research platform for the treatment of various inflammatory diseases. Raphael’s lead product candidate is a highly purified cannabinoid formulation specifically developed for the treatment of rheumatoid arthritis.

For more information, please visit https://www.raphaelpharmaceutical.com/.

Raphael Pharmaceutical Inc (OTCMRKTS: RAPH) Stock Message Board

1. RAPH Company Profile

    

2. RAPH Time & Sales

    

3. RAPH Recent News

    

4. RAPH Filings

    

5. RAPH Financials

    

6. RAPH Buy Rating

Create New Post View All Posts Board Mark Banned

Post

Subject

Author

Posted On

1

$RAPH Raphael Pharmaceutical Announces Positive

louied91

01/07/2025 9:20:00 AM

Recent Articles

• Jim Rickards Highlights Hidden US Resource Wealth and Potential
• Exciting Insights on PALSONIFY's Effectiveness in Acromegaly
• BAY Miner Transforms Crypto Mining with Innovative Platform
• Investors Urged to Act on DoubleVerify Holdings Class Action
• BAY Miner Launches Innovative Cloud Mining for Crypto Enthusiasts
• Investigation into Laser Photonics Corporation: Key Details
• XPLR Investors Encouraged to Join Class Action for Justice
• Centene Corporation Class Action Lawsuit Update and Details
• Revolutionizing Digital Wealth: Invro Mining's Unique Approach
• Mastering Wealth: Charlie Munger's Three-Step Guide
• Empowering Users: Discover SunnyMining's New Cloud App
• Menerals: A Bold Step Towards Restoring Male Vitality
• PFMCrypto Launches Innovative BTC Cloud Mining Solution
• Discover the Future of Earning with SunnyMining’s Mobile App
• Understanding the Power of 'No' in Elon Musk's Journey
• Investors Urged to Join iRobot Securities Class Action Quickly
• Exploring the Impact of Epstein's Claims About Trump
• Explosive Tapes Reveal Epstein's Close Friendship with Trump
• Investors Unite: Sarepta Therapeutics Faces Legal Challenges Ahead
• Iovance Biotherapeutics Faces Securities Fraud Litigation for 2025
• Discover the Future of Mining with ALL4Mining's AI System
• DNSBTC Introduces Eco-Friendly Cloud Mining Solutions
• Ray Dalio's Insights on Strategic Diversification in Investing
• Investors Should Explore Options After SelectQuote's Recent Troubling Developments
• Investor Alert: Backblaze, Inc. Facing Shareholder Rights Investigations
• Investors Encouraged to Act in 3D Systems Securities Case
• Transforming Cryptocurrency Mining with DRML Miner Technology
• Apple's Management Changes: A New Era Under Tim Cook
• Important Legal Reminder for Apple Inc. Investors Ahead of Deadline
• Unlock Daily Rewards with PFMCrypto’s XRP Cloud Mining
• Memecoin Platform Strikes Big, Raising $600 Million Instantly
• Top Large Cap Stocks Facing Declines: A Closer Look
• JAMining Enhances XRP Mining Experience with Innovative Contracts
• Unlocking Profitable Home Mining with RDG Mining's Easy Platform
• Unlocking Passive Income: Your Smartphone's Secret Weapons
• XRP Whale Accumulation Fuels Innovative Mining Opportunities
• Earnings Season Prevails Amid Trade War Concerns
• AIXA Miner Unveils Innovative AI Mining Platform for 2025
• Explore Passive Income with DEAL Mining's New Mobile App
• DEAL Mining Releases User-Friendly App for Cloud Mining
• Mark Cuban Advocates for the Future of Olympic Basketball Talent
• Rocket Pharmaceuticals Investors: Important Class Action Update
• DoubleVerify Holdings: Investors Might Claim Securities Fraud
• Unlocking Passive Income with Okalio Mining's Cloud Solutions
• Unlock Passive Income with the Revolutionary XRP Mining App
• PaladinMining Unlocks Potential for XRP Investors and Miners
• Revolutionizing Crypto Mining: Your Smartphone's New Role
• Top Large-Cap Performers: A Review of Recent Gains
• Discover Free Cloud Mining: Join Find Mining Revolution Now
• Legal Guidance for Western Asset Management Mutual Fund Investors